TWO SIGMA INVESTMENTS, LP - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 144 filers reported holding THERAPEUTICSMD INC in Q3 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q4 2021$65,000
+282.4%
183,651
+721.7%
0.00%
Q3 2021$17,000
-97.4%
22,351
-95.5%
0.00%
-100.0%
Q1 2021$659,000
+317.1%
491,836
+289.7%
0.00%
+100.0%
Q2 2020$158,000
+11.3%
126,224
-5.6%
0.00%0.0%
Q1 2020$142,000
-95.1%
133,754
-88.9%
0.00%
-88.9%
Q4 2019$2,921,000
+3743.4%
1,207,214
+10678.7%
0.01%
Q3 2016$76,00011,2000.00%
Other shareholders
THERAPEUTICSMD INC shareholders Q3 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,460,225$24,914,0004.95%
Newtyn Management, LLC 1,800,000$12,960,0001.95%
1492 Capital Management LLC 222,485$1,602,0001.25%
SANDERS MORRIS HARRIS LLC 967,200$6,964,0001.18%
MORGENS WATERFALL VINTIADIS & CO INC 180,000$1,296,0001.15%
SPHERA FUNDS MANAGEMENT LTD. 580,000$4,176,0000.82%
Rock Springs Capital Management LP 1,600,000$11,520,0000.66%
STONERIDGE INVESTMENT PARTNERS LLC 467,425$3,365,0000.45%
Capital Impact Advisors, LLC 157,411$1,133,0000.45%
GILDER GAGNON HOWE & CO LLC 3,059,690$22,030,0000.37%
View complete list of THERAPEUTICSMD INC shareholders